Opioid-modulating properties of the neuropeptide FF system

BioFactors

Volumn 36, Issue 6, 2010, Pages 423-429

  Moulédous, Lionel ^a   Mollereau, Catherine ^a   Zajac, Jean Marie ^a  

^a INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

Author keywords

G protein coupled receptor; NPFF; Opioid tolerance; Pain

Indexed keywords

CARBACHOL; DELTA OPIATE RECEPTOR; DELTA OPIATE RECEPTOR AGONIST; DIAMORPHINE; ENKEPHALIN; MORPHINE; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR AGONIST; NALOXONE; NEUROPEPTIDE FF; OPIATE ANTAGONIST; OPIATE RECEPTOR;

ACETYLCHOLINE RELEASE; ANALGESIA; ANALGESIC ACTIVITY; ANTINOCICEPTION; ARTICLE; BRAIN SLICE; DOPAMINERGIC NERVE CELL; DORSAL RAPHE NUCLEUS; DRINKING BEHAVIOR; DRUG HYPERSENSITIVITY; DRUG INHIBITION; DRUG MEGADOSE; DRUG RESPONSE; ENZYME ACTIVATION; FEEDING; FLUORESCENCE RESONANCE ENERGY TRANSFER; FOOD INTAKE; HUMAN; HYPERALGESIA; IMMUNOREACTIVITY; INTESTINE MOTILITY; LOCOMOTION; LOW DRUG DOSE; MOLECULAR INTERACTION; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; OPIATE ADDICTION; OUTCOME ASSESSMENT; PAIN; PAIN THRESHOLD; PLACE PREFERENCE; POSTSYNAPTIC POTENTIAL; PRESYNAPTIC INHIBITION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SPINAL GANGLION; SYNAPTIC TRANSMISSION; TAIL FLICK TEST; VENTRAL TEGMENTUM;

AMINO ACID SEQUENCE; ANALGESICS, OPIOID; ANIMALS; CATTLE; HUMANS; MICE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MORPHINE; NEURONS; OLIGOPEPTIDES; OPIOID PEPTIDES; RATS; RECEPTOR CROSS-TALK; RECEPTORS, OPIOID;

EID: 78650125304     PISSN: 09516433     EISSN: 18728081     Source Type: Journal    
DOI: 10.1002/biof.116     Document Type: Article

References (89)

1. Yang, H. Y., Fratta, W., Majane, E. A., and Costa, E. ( 1985) Isolation, sequencing, synthesis, and pharmacological characterization of two brain neuropeptides that modulate the action of morphine. Proc. Natl. Acad. Sci. USA 82, 7757-7761.
2. Zajac, J. M. ( 2001) Neuropeptide FF: new molecular insights. Trends Pharmacol. Sci. 22, 63.
3. Bonini, J. A., Jones, K. A., Adham, N., Forray, C., Artymyshyn, R., Durkin, M. M., Smith, K. E., Tamm, J. A., Boteju, L. W., Lakhlani, P. P., Raddatz, R., Yao, W. J., Ogozalek, K. L., Boyle, N., Kouranova, E. V., Quan, Y., Vaysse, P. J., Wetzel, J. M., Branchek, T. A., Gerald, C., and Borowsky, B. ( 2000) Identification and characterization of two G protein-coupled receptors for neuropeptide FF. J. Biol. Chem. 275, 39324-39331.
4. Elshourbagy, N. A., Ames, R. S., Fitzgerald, L. R., Foley, J. J., Chambers, J. K., Szekeres, P. G., Evans, N. A., Schmidt, D. B., Buckley, P. T., Dytko, G. M., Murdock, P. R., Milligan, G., Groarke, D. A., Tan, K. B., Shabon, U., Nuthulaganti, P., Wang, D. Y., Wilson, S., Bergsma, D. J., and Sarau, H. M. ( 2000) Receptor for the pain modulatory neuropeptides FF and AF is an orphan G protein-coupled receptor. J. Biol. Chem. 275, 25965-25971.
5. Hinuma, S., Shintani, Y., Fukusumi, S., Iijima, N., Matsumoto, Y., Hosoya, M., Fujii, R., Watanabe, T., Kikuchi, K., Terao, Y., Yano, T., Yamamoto, T., Kawamata, Y., Habata, Y., Asada, M., Kitada, C., Kurokawa, T., Onda, H., Nishimura, O., Tanaka, M., Ibata, Y., and Fujino, M. ( 2000) New neuropeptides containing carboxy-terminal RFamide and their receptor in mammals. Nat. Cell Biol. 2, 703-708.
6. Kotani, M., Mollereau, C., Detheux, M., Le Poul, E., Brezillon, S., Vakili, J., Mazarguil, H., Vassart, G., Zajac, J. M., and Parmentier, M. ( 2001) Functional characterization of a human receptor for neuropeptide FF and related peptides. Br. J. Pharmacol. 133, 138-144.
7. Liu, Q., Guan, X. M., Martin, W. J., McDonald, T. P., Clements, M. K., Jiang, Q., Zeng, Z., Jacobson, M., Williams, D. L., Jr., Yu, H., Bomford, D., Figueroa, D., Mallee, J., Wang, R., Evans, J., Gould, R., and Austin, C. P. ( 2001) Identification and characterization of novel mammalian neuropeptide FF-like peptides that attenuate morphine-induced antinociception. J. Biol. Chem. 276, 36961-36969.
8. Perry, S. J., Yi-Kung Huang, E., Cronk, D., Bagust, J., Sharma, R., Walker, R. J., Wilson, S., and Burke, J. F. ( 1997) A human gene encoding morphine modulating peptides related to NPFF and FMRFamide. FEBS Lett. 409, 426-430.
9. Vilim, F. S., Aarnisalo, A. A., Nieminen, M. L., Lintunen, M., Karlstedt, K., Kontinen, V. K., Kalso, E., States, B., Panula, P., and Ziff, E. ( 1999) Gene for pain modulatory neuropeptide NPFF: induction in spinal cord by noxious stimuli. Mol. Pharmacol. 55, 804-811.
10. Fukusumi, S., Fujii, R., and Hinuma, S. ( 2006) Recent advances in mammalian RFamide peptides: the discovery and functional analyses of PrRP, RFRPs and QRFP. Peptides 27, 1073-1086.
11. Mollereau, C., Mazarguil, H., Marcus, D., Quelven, I., Kotani, M., Lannoy, V., Dumont, Y., Quirion, R., Detheux, M., Parmentier, M., and Zajac, J. M. ( 2002) Pharmacological characterization of human NPFF(1) and NPFF(2) receptors expressed in CHO cells by using NPY Y(1) receptor antagonists. Eur. J. Pharmacol. 451, 245-256.
12. Roumy, M. and Zajac, J. M. ( 1998) Neuropeptide FF, pain and analgesia. Eur. J. Pharmacol. 345, 1-11.
13. Yang, H. Y., Tao, T., and Iadarola, M. J. ( 2008) Modulatory role of neuropeptide FF system in nociception and opiate analgesia. Neuropeptides 42, 1-18.
14. Panula, P., Aarnisalo, A. A., and Wasowicz, K. ( 1996) Neuropeptide FF, a mammalian neuropeptide with multiple functions. Prog. Neurobiol. 48, 461-487.
15. Smith, J. T. and Clarke, I. J. ( 2010) Gonadotropin inhibitory hormone function in mammals. Trends Endocrinol. Metab. 21, 255-260.
16. Mollereau, C., Roumy, M., and Zajac, J. M. ( 2005) Opioid-modulating peptides: mechanisms of action. Curr. Top. Med. Chem. 5, 341-355.
17. Gouarderes, C., Puget, A., and Zajac, J. M. ( 2004) Detailed distribution of neuropeptide FF receptors (NPFF1 and NPFF2) in the rat, mouse, octodon, rabbit, guinea pig, and marmoset monkey brains: a comparative autoradiographic study. Synapse 51, 249-269.
18. Gicquel, S., Mazarguil, H., Allard, M., Simonnet, G., and Zajac, J. M. ( 1992) Analogues of F8Famide resistant to degradation, with high affinity and in vivo effects. Eur. J. Pharmacol. 222, 61-67.
19. Oberling, P., Stinus, L., Le Moal, M., and Simonnet, G. ( 1993) Biphasic effect on nociception and antiopiate activity of the neuropeptide FF (FLFQPQRFamide) in the rat. Peptides 14, 919-924.
20. Desprat, C. and Zajac, J. M. ( 1997) Differential modulation of mu- and delta-opioid antinociception by neuropeptide FF receptors in young mice. Neuropeptides 31, 1-7.
21. Kavaliers, M. ( 1990) Inhibitory influences of mammalian FMRFamide (Phe-Met-Arg-Phe-amide)-related peptides on nociception and morphine- and stress-induced analgesia in mice. Neurosci. Lett. 115, 307-312.
22. Altier, N. and Stewart, J. ( 1997) Neuropeptide FF in the VTA blocks the analgesic effects of both intra-VTA morphine and exposure to stress. Brain Res. 758, 250-254.
23. Dupouy, V. and Zajac, J. M. ( 1997) Neuropeptide FF receptors control morphine-induced analgesia in the parafascicular nucleus and the dorsal raphe nucleus. Eur. J. Pharmacol. 330, 129-137.
24. Wei, H., Panula, P., and Pertovaara, A. ( 1998) A differential modulation of allodynia, hyperalgesia and nociception by neuropeptide FF in the periaqueductal gray of neuropathic rats: interactions with morphine and naloxone. Neuroscience 86, 311-319.
25. Gouarderes, C., Sutak, M., Zajac, J. M., and Jhamandas, K. ( 1993) Antinociceptive effects of intrathecally administered F8Famide and FMRFamide in the rat. Eur. J. Pharmacol. 237, 73-81.
26. Kontinen, V. K. and Kalso, E. A. ( 1995) Differential modulation of alpha 2-adrenergic and mu-opioid spinal antinociception by neuropeptide FF. Peptides 16, 973-977.
27. Xu, M., Kontinen, V. K., Panula, P., and Kalso, E. ( 1999) Effects of (1DMe)NPYF, a synthetic neuropeptide FF analogue, in different pain models. Peptides 20, 1071-1077.
28. Altier, N., Dray, A., Menard, D., and Henry, J. L. ( 2000) Neuropeptide FF attenuates allodynia in models of chronic inflammation and neuropathy following intrathecal or intracerebroventricular administration. Eur. J. Pharmacol. 407, 245-255.
29. Kontinen, V. K., Aarnisalo, A. A., Idanpaan-Heikkila, J. J., Panula, P., and Kalso, E. ( 1997) Neuropeptide FF in the rat spinal cord during carrageenan inflammation. Peptides 18, 287-292.
30. Wei, H., Panula, P., and Pertovaara, A. ( 2001) Modulation of pain by [1DMe]NPYF, a stable analogue of neuropeptide FF, in neuropathic rats. Brain Res. 900, 234-243.
31. Quelven, I., Roussin, A., Burlet-Schiltz, O. Gouarderes, C., Tafani, J. A., Mazarguil, H., and Zajac, J. M. ( 2002) Dissociation of pharmacological pro- and anti-opioid effects by neuropeptide FF analogs. Eur. J. Pharmacol. 449, 91-98.
32. Gouarderes, C., Jhamandas, K., Sutak, M., and Zajac, J. M. ( 1996) Role of opioid receptors in the spinal antinociceptive effects of neuropeptide FF analogues. Br. J. Pharmacol. 117, 493-501.
33. Courteix, C., Coudore-Civiale, M. A., Privat, A. M., Zajac, J. M., Eschalier, A., and Fialip, J. ( 1999) Spinal effect of a neuropeptide FF analogue on hyperalgesia and morphine-induced analgesia in mononeuropathic and diabetic rats. Br. J. Pharmacol. 127, 1454-1462.
34. Xu, M., Kontinen, V. K., Panula, P., and Kalso, E. ( 2001) Role of the delta-opioid receptor in (1DMe)NPYF mediated antinociception. Peptides 22, 33-38.
35. Gouarderes, C., Sutak, M., Zajac, J. M., and Jhamandas, K. ( 2000) Role of adenosine in the spinal antinociceptive and morphine modulatory actions of neuropeptide FF analogs. Eur. J. Pharmacol. 406, 391-401.
36. Ballet, S., Mauborgne, A., Gouarderes, C., Bourgoin, A. S., Zajac, J. M., Hamon, M., and Cesselin, F. ( 1999) The neuropeptide FF analogue, 1DME, enhances in vivo met-enkephalin release from the rat spinal cord. Neuropharmacology 38, 1317-1324.
37. Mauborgne, A., Bourgoin, S., Polienor, H., Roumy, M., Simonnet, G., Zajac, J. M., and Cesselin, F. ( 2001) The neuropeptide FF analogue, 1DMe, acts as a functional opioid autoreceptor antagonist in the rat spinal cord. Eur. J. Pharmacol. 430, 273-276.
38. Ballet, S., Braz, J., Mauborgne, A., Bourgoin, S., Zajac, J. M., Hamon, M., and Cesselin, F. ( 2002) The neuropeptide FF analogue, 1DMe, reduces in vivo dynorphin release from the rat spinal cord. J. Neurochem. 81, 659-662.
39. Quelven, I., Roussin, A., and Zajac, J. M. ( 2005) Comparison of pharmacological activities of Neuropeptide FF1 and Neuropeptide FF2 receptor agonists. Eur. J. Pharmacol. 508, 107-114.
40. Fang, Q., Guo, J., He, F., Peng, Y. L., Chang, M., and Wang, R. ( 2006) In vivo inhibition of neuropeptide FF agonism by BIBP3226, an NPY Y1 receptor antagonist. Peptides 27, 2207-2213.
41. Roussin, A., Serre, F., Gouarderes, C., Mazarguil, H., Roumy, M., Mollereau, C., and Zajac, J. M. ( 2005) Anti-analgesia of a selective NPFF2 agonist depends on opioid activity. Biochem. Biophys. Res. Commun. 336, 197-203.
42. Fang, Q., Wang, Y. Q., He, F., Guo, J., Chen, Q., and Wang, R. ( 2008) Inhibition of neuropeptide FF (NPFF)-induced hypothermia and anti-morphine analgesia by RF9, a new selective NPFF receptors antagonist. Regul. Pept. 147, 45-51.
43. Laurent, P., Becker, J. A., Valverde, O., Ledent, C., de Kerchove d'Exaerde, A., Schiffmann, S. N., Maldonado, R., Vassart, G., and Parmentier, M. ( 2005) The prolactin-releasing peptide antagonizes the opioid system through its receptor GPR10. Nat. Neurosci. 8, 1735-1741.
44. Rothman, R. B. ( 1992) A review of the role of anti-opioid peptides in morphine tolerance and dependence. Synapse 12, 129-138.
45. Malin, D. H., Lake, J. R., Hammond, M. V., Fowler, D. E., Rogillio, R. B., Brown, S. L., Sims, J. L., Leecraft, B. M., and Yang, H. Y. ( 1990) FMRF-NH2-like mammalian octapeptide: possible role in opiate dependence and abstinence. Peptides 11, 969-972.
46. Devillers, J. P., Boisserie, F., Laulin, J. P., Larcher, A., and Simonnet, G. ( 1995) Simultaneous activation of spinal antiopioid system (neuropeptide FF) and pain facilitatory circuitry by stimulation of opioid receptors in rats. Brain Res. 700, 173-181.
47. Stinus, L., Allard, M., Gold, L., and Simonnet, G. ( 1995) Changes in CNS neuropeptide FF-like material, pain sensitivity, and opiate dependence following chronic morphine treatment. Peptides 16, 1235-1241.
48. Nystedt, J. M., Lemberg, K., Lintunen, M., Mustonen, K., Holma, R., Kontinen, V. K., Kalso, E., and Panula, P. ( 2004) Pain- and morphine-associated transcriptional regulation of neuropeptide FF and the G-protein-coupled NPFF2 receptor gene. Neurobiol. Dis. 16, 254-262.
49. Goodman, C. B., Emilien, B., Becketts, K., Cadet, J. L., and Rothman, R. B. ( 1996) Downregulation of mu-opioid binding sites following chronic administration of neuropeptide FF (NPFF) and morphine. Peptides 17, 389-397.
50. Lake, J. R., Hammond, M. V., Shaddox, R. C., Hunsicker, L. M., Yang, H. Y., and Malin, D. H. ( 1991) IgG from neuropeptide FF antiserum reverses morphine tolerance in the rat. Neurosci. Lett. 132, 29-32.
51. Gelot, A., Frances, B., Gicquel, S., and Zajac, J. M. ( 1998) Antisense oligonucleotides to human SQA-neuropeptide FF decrease morphine tolerance and dependence in mice. Eur. J. Pharmacol. 358, 203-206.
52. Simonin, F., Schmitt, M., Laulin, J. P., Laboureyras, E., Jhamandas, J. H., MacTavish, D., Matifas, A., Mollereau, C., Laurent, P., Parmentier, M., Kieffer, B. L., Bourguignon, J. J., and Simonnet, G. ( 2006) RF9, a potent and selective neuropeptide FF receptor antagonist, prevents opioid-induced tolerance associated with hyperalgesia. Proc. Natl. Acad. Sci. USA 103, 466-471.
53. Bonnard, E., Mazarguil, H., and Zajac, J. M. ( 2002) Peptide nucleic acids targeted to the mouse proNPFF(A) reveal an endogenous opioid tonus. Peptides 23, 1107-1113.
54. Jhamandas, K., Milne, B., Sutak, M., Gouarderes, C., Zajac, J. M., and Yang, H. Y. ( 2006) Facilitation of spinal morphine analgesia in normal and morphine tolerant animals by neuropeptide SF and related peptides. Peptides 27, 953-963.
55. Malin, D. H., Lake, J. R., Fowler, D. E., Hammond, M. V., Brown, S. L., Leyva, J. E., Prasco, P. E., and Dougherty, T. M. ( 1990) FMRF-NH2-like mammalian peptide precipitates opiate-withdrawal syndrome in the rat. Peptides 11, 277-280.
56. Malin, D. H., Lake, J. R., Jones, J. A., Morel, J., Moon, W. D., Corbit, B. P., Smith, D. A., Claunch, A. E., Kacher, D., Stevens, P. A., and Webb, S. L. ( 1996) Nitric oxide synthesis inhibition attenuates behavioral actions of neuropeptide FF. Peptides 17, 615-618.
57. Herz, A. ( 1998) Opioid reward mechanisms: a key role in drug abuse? Can. J. Physiol. Pharmacol. 76, 252-258.
58. Marchand, S., Betourne, A., Marty, V., Daumas, S., Halley, H., Lassalle, J. M., Zajac, J. M., and Frances, B. ( 2006) A neuropeptide FF agonist blocks the acquisition of conditioned place preference to morphine in C57Bl/6J mice. Peptides 27, 964-972.
59. Kotlinska, J., Pachuta, A., Dylag, T., and Silberring, J. ( 2007) Neuropeptide FF (NPFF) reduces the expression of morphine- but not of ethanol-induced conditioned place preference in rats. Peptides 28, 2235-2242.
60. Wu, C. H., Tao, P. L., and Huang, E. Y. ( 2010) Distribution of neuropeptide FF (NPFF) receptors in correlation with morphine-induced reward in the rat brain. Peptides 31, 1374-1382.
61. Mouledous, L., Frances, B., and Zajac, J. M. ( 2010) Modulation of basal and morphine-induced neuronal activity by a NPFF(2) selective agonist measured by c-Fos mapping of the mouse brain. Synapse 64, 672-681.
62. Marco, N., Stinus, L., Allard, M., Le Moal, M., and Simonnet, G. ( 1995) Neuropeptide FLFQRFamide receptors within the ventral mesenchephalon and dopaminergic terminal areas: localization and functional antiopioid involvement. Neuroscience 64, 1035-1044.
63. Cador, M., Marco, N., Stinus, L., and Simonnet, G. ( 2002) Interaction between neuropeptide FF and opioids in the ventral tegmental area in the behavioral response to novelty. Neuroscience 110, 309-318.
64. Kotlinska, J., Pachuta, A., Dylag, T., and Silberring, J. ( 2007) The role of neuropeptide FF (NPFF) in the expression of sensitization to hyperlocomotor effect of morphine and ethanol. Neuropeptides 41, 51-58.
65. Murase, T., Arima, H., Kondo, K., and Oiso, Y. ( 1996) Neuropeptide FF reduces food intake in rats. Peptides 17, 353-354.
66. Nicklous, D. M. and Simansky, K. J. ( 2003) Neuropeptide FF exerts pro- and anti-opioid actions in the parabrachial nucleus to modulate food intake. Am. J. Physiol. Regul. Integr. Comp. Physiol. 285, R1046-R1054.
67. Sunter, D., Hewson, A. K., Lynam, S., and Dickson, S. L. ( 2001) Intracerebroventricular injection of neuropeptide FF, an opioid modulating neuropeptide, acutely reduces food intake and stimulates water intake in the rat. Neurosci. Lett. 313, 145-148.
68. Arima, H., Murase, T., Kondo, K., Iwasaki, Y., and Oiso, Y. ( 1996) Centrally administered neuropeptide FF inhibits arginine vasopressin release in conscious rats. Endocrinology 137, 1523-1529.
69. Raffa, R. B. and Jacoby, H. I. ( 1989) A-18-famide and F-8-famide, endogenous mammalian equivalents of the molluscan neuropeptide FMRFamide (Phe-Met-Arg-Phe-NH2), inhibit colonic bead expulsion time in mice. Peptides 10, 873-875.
70. Million, M., Fioramonti, J., Gicquel, S., Zajac, J. M., and Bueno, L. ( 1993) Comparative action of Phe-Leu-Phe-Gln-Pro-Gln-Arg-Phe-NH2 analogs on intestinal motility and nociception in rats. J. Pharmacol. Exp. Ther. 265, 96-102.
71. Gelot, A., Fioramonti, J., Zajac, J. M., and Bueno, L. ( 1995) Central effects of neuropeptide FF on intestinal motility in naive and morphine-dependent rats. Neuropeptides 29, 245-250.
72. Demichel, P., Rodriguez, J. C., Roquebert, J., and Simonnet, G. ( 1993) NPFF, a FMRF-NH2-like peptide, blocks opiate effects on ileum contractions. Peptides 14, 1005-1009.
73. Gouarderes, C., Roumy, M., Advokat, C., Jhamandas, K., and Zajac, J. M. ( 2000) Dual localization of neuropeptide FF receptors in the rat dorsal horn. Synapse 35, 45-52.
74. Magnuson, D. S., Sullivan, A. F., Simonnet, G., Roques, B. P., and Dickenson, A. H. ( 1990) Differential interactions of cholecystokinin and FLFQPQRF-NH2 with mu and delta opioid antinociception in the rat spinal cord. Neuropeptides 16, 213-218.
75. Chen, X., Zidichouski, J. A., Harris, K. H., and Jhamandas, J. H. ( 2000) Synaptic actions of neuropeptide FF in the rat parabrachial nucleus: interactions with opioid receptors. J. Neurophysiol. 84, 744-751.
76. Miller, K. K. and Lupica, C. R. ( 1997) Neuropeptide FF inhibition of morphine effects in the rat hippocampus. Brain Res. 750, 81-86.
77. Takeuchi, T., Fujita, A., Roumy, M., Zajac, J. M., and Hata, F. ( 2001) Effect of 1DMe, a neuropeptide FF analog, on acetylcholine release from myenteric plexus of guinea pig ileum. Jpn. J. Pharmacol. 86, 417-422.
78. Rebeyrolles, S., Zajac, J. M., and Roumy, M. ( 1996) Neuropeptide FF reverses the effect of mu-opioid on Ca2+ channels in rat spinal ganglion neurones. Neuroreport 7, 2979-2981.
79. Roumy, M. and Zajac, J. ( 1999) Neuropeptide FF selectively attenuates the effects of nociceptin on acutely dissociated neurons of the rat dorsal raphe nucleus. Brain. Res. 845, 208-214.
80. Gouarderes, C., Quelven, I., Mollereau, C., Mazarguil, H., Rice, S. Q., and Zajac, J. M. ( 2002) Quantitative autoradiographic distribution of NPFF1 neuropeptide FF receptor in the rat brain and comparison with NPFF2 receptor by using [125I]YVP and [125I]EYF as selective radioligands. Neuroscience 115, 349-361.
81. Roumy, M., Gouarderes, C., Mazarguil, H., and Zajac, J. M. ( 2000) Are neuropeptides FF and SF neurotransmitters in the rat? Biochem. Biophys. Res. Commun. 275, 821-824.
82. Roumy, M., Garnier, M., and Zajac, J. M. ( 2003) Neuropeptide FF receptors 1 and 2 exert an anti-opioid activity in acutely dissociated rat dorsal raphe and periventricular hypothalamic neurones. Neurosci. Lett. 348, 159-162.
83. Mollereau, C., Mazarguil, H., Zajac, J. M., and Roumy, M. ( 2005) Neuropeptide FF (NPFF) analogs functionally antagonize opioid activities in NPFF2 receptor-transfected SH-SY5Y neuroblastoma cells. Mol. Pharmacol. 67, 965-975.
84. Kersante, F., Mollereau, C., Zajac, J. M., and Roumy, M. ( 2006) Anti-opioid activities of NPFF1 receptors in a SH-SY5Y model. Peptides 27, 980-989.
85. Roumy, M., Lorenzo, C., Mazeres, S., Bouchet, S., Zajac, J. M., and Mollereau, C. ( 2007) Physical association between neuropeptide FF and micro-opioid receptors as a possible molecular basis for anti-opioid activity. J. Biol. Chem. 282, 8332-8342.
86. Rozenfeld, R. and Devi, L. A. ( 2010) Receptor heteromerization and drug discovery. Trends. Pharmacol. Sci. 31, 124-130.
87. Mouledous, L., Merker, S., Neasta, J., Roux, B., Zajac, J. M., and Mollereau, C. ( 2008) Neuropeptide FF-sensitive confinement of mu opioid receptor does not involve lipid rafts in SH-SY5Y cells. Biochem. Biophys. Res. Commun. 373, 80-84.
88. Mollereau, C., Zajac, J. M., and Roumy, M. ( 2007) Staurosporine differentiation of NPFF(2) receptor-transfected SH-SY5Y neuroblastoma cells induces selectivity of NPFF activity towards opioid receptors. Peptides 28, 1125-1128.
89. Kersante, F., Mouledous, L., Zajac, J. M., and Mollereau, C. ( 2010) Modulation by Neuropeptide FF of the interaction of Mu-opioid (MOP) receptor with G-proteins. Neurochem. Int. 56, 768-773.